The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions In Gastric Cancer By Targeting The miR-302b-3p/E2F

Chaojie Liang1, Chaosen Yue2, Chaowei Liang1

  • 1Department of General Surgery, First Hospital/First Clinical Medical College of Shanxi Medical University, Taiyuan, Shanxi 030001, People's Republic of China.

Oncotargets and Therapy
|December 6, 2019
PubMed
Abstract

Insights

The long non-coding RNA SBF2-AS1 is overexpressed in gastric cancer (GC), promoting tumor progression. Targeting SBF2-AS1 may offer a new diagnostic and prognostic strategy for GC patients.

Area of Science:

  • Molecular Oncology
  • Cancer Genomics

Background:

  • Long non-coding RNA SBF2-AS1 is implicated in cancer progression.
  • Its specific role in gastric cancer (GC) remains largely unexplored.

Purpose of the Study:

  • To investigate the mechanism of SBF2-AS1 in gastric cancer.
  • To evaluate SBF2-AS1 as a diagnostic and prognostic biomarker for GC.

Main Methods:

  • Meta-analysis of public datasets (GEO, TCGA) for prognostic value.
  • RT-PCR for clinicopathologic correlation.
  • In vitro gain/loss-of-function assays in GC cell lines.
  • Luciferase reporter and bioinformatics for target validation.

Main Results:

  • SBF2-AS1 is significantly overexpressed in GC tissues and cell lines.
  • High SBF2-AS1 expression correlates with poor overall survival and serves as an independent prognostic factor.
  • SBF2-AS1 knockdown inhibits GC cell growth, invasion, and metastasis while promoting apoptosis and cell cycle arrest.
  • SBF2-AS1 functions as a competing endogenous RNA (ceRNA) for miR-302b-3p, thereby inhibiting miR-302b-3p's suppression of E2F3.

Conclusions:

  • SBF2-AS1 is a potential diagnostic and prognostic biomarker for gastric cancer.
  • SBF2-AS1 promotes GC progression through the miR-302b-3p/E2F3 signaling axis.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K